AGL (agilon health, inc.) Stock Analysis - SEC Filings

agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find AGL SEC filings?

Rallies organizes AGL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

AGL Key Metrics

Key financial metrics for AGL
MetricValue
Price$80.01
Market Cap$1.45B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$152.00
52-Week Low$7.48
Volume28
Avg Volume0
Revenue (TTM)$5.82B
Net Income$-354.54M
Gross Margin0.00%

Latest AGL News

Recent AGL Insider Trades

  • Shaker Benjamin bought 500.00K (~$301.05K) on Mar 2, 2026.
  • Wulf John William bought 81.00K (~$50.94K) on Nov 12, 2025.
  • McLoughlin Karen bought 25.00K (~$55.08K) on Dec 13, 2024.

AGL Analyst Consensus

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.

Common questions about AGL

Where can I find AGL SEC filings?
Rallies organizes AGL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show AGL 10-K and 10-Q filings?
Rallies organizes AGL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is AGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.
AGL

AGL